IWC
CNSP icon

Integrated Wealth Concepts’s CNS Pharmaceuticals CNSP Stock Holding History

Integrated Wealth Concepts’s Portfolio CNSP Stock Details CNSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-417
Closed -$30.1K – 1760
2024
Q4 		$30.1K Buy
+417
New +$29.7K ﹤0.01% 1700

Other funds holding CNSP

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BC
Barrett & Company Providence, Rhode Island $357M AUM 22.45% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Integrated Wealth Concepts's CNSP Position: Q1 2025 in Review

Integrated Wealth Concepts sold out of CNS Pharmaceuticals (CNSP) in Q1 2025, closing a stake of 417 shares — an estimated $30.1K sold.

Integrated Wealth Concepts first reported a position in CNSP in Q4 2024 and held it in 1 quarter. The position peaked at $30.1K in Q4 2024. 7 funds tracked by Wall St. Rank hold CNSP as of Q1 2025.

  • Integrated Wealth Concepts reported no remaining CNS Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Integrated Wealth Concepts sold 417 CNS Pharmaceuticals shares in Q1 2025, an estimated $30.1K.
  • Integrated Wealth Concepts first reported a position in CNS Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Integrated Wealth Concepts's CNS Pharmaceuticals position peaked at $30.1K in Q4 2024.
  • 7 funds tracked by Wall St. Rank held CNS Pharmaceuticals as of Q1 2025.

Based on Integrated Wealth Concepts's 13F filing for Q1 2025, filed 15 May 2025.